NASDAQInformation TechnologySemiconductorsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for MOBX yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Successful acquisition and integration of Vision Aerial | Mobix Labs aims to grow by acquiring Vision Aerial, expanding into drones. | Under Pressure | acquisition fails or is abandoned by end of 2026 | Acquisition terminated vs complete by 2026-Q4 Form 8-K filed Oct 19, 2026 confirms termination of the Vision Aerial Merger Agreement dated July 24, 2026. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative, high-risk business rather than a proven compounder. Its long-term thesis is on watch: recent performance has been weak relative to its industry cohort, and the signal recently shifted from mixed to cautious.
The evidence describes MOBX as cheap versus peers, but confidence in that valuation view is low. The stock still carries an 18% premium versus peers in the supplied measure, so the valuation evidence is mixed and does not show how much optimism or concern is already reflected.
In the near term, results and management execution remain uncertain: the company is loss-making, recent performance is weak, and priorities to improve revenue and gross margin are still being watched. The planned platform expansions through acquisitions are also uncertain, following a material agreement termination on October 19 after positive acquisition-related events in August.
The multi-year thesis depends on improving revenue and gross margin and on whether the drone, autonomous systems, and national security expansion plans advance. Near term, a guidance cut would be a meaningful negative; easing interest rates or steadier results and guidance from major technology companies could support the sector backdrop.
Over the next 1 to 3 years, MOBX remains a high-risk, loss-making watch case, with the thesis hinging on execution and acquisition progress. The evidence is mixed and confidence is medium. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| These moves could improve its weak cash flow and loss-making status. |
| Broken |
| free cash flow yield remains below -5% over next year |
Valuation inputs unavailable A completed valuation measurement is required. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Gross margin near 50.35% in fiscal 2025 | The company targets about $9.8 million revenue and 50.35% gross margin next year. | Broken | gross margin falls below 45% in fiscal 2025 | Gross margin: 12.93% FY2026-Q3; GAAP. Published target: ~50.35%. Target period ends 2025-09-30; this observation covers 2026-Q3. Aug 17, 202612.927757 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue reaches about $9.8 million in fiscal 2025 | The company targets about $9.8 million revenue and 50.35% gross margin next year. | Intact | revenue falls below $9.0 million in fiscal 2025 | Revenue: $789,000 FY2026-Q3; GAAP. Published target: ~$9.8 million. Target period ends 2025-09-30; this observation covers 2026-Q3. Aug 17, 2026789,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.